Corporate News – Market Update for Jazz Pharmaceuticals PLC
Trading Performance
- Closing Price (24‑hour period ending 02:36 PM CET, Friday 23 Oct 2026): USD 214.65
- Price Change: Up 1.26 % during the 24‑hour period.
- Market Capitalisation: USD 13.8 bn.
- Shares Outstanding: 62.8 million.
- Total Volume Traded (last 24 hours): USD 168.2 million.
- Price Trend Since Month‑End: Down 8.61 %.
- Simple Moving Average (200 days): USD 215.29.
- 52‑Week High: USD 266.38 (recorded 25 Aug 2026).
- 52‑Week Low: USD 128.80 (recorded 7 Nov 2025).
Comparative Performance of Related Stocks
| Symbol | Last 24‑Hour Change | Current Price | Market Capitalisation | P/E Ratio | Notes |
|---|---|---|---|---|---|
| JHX | +0.91 % | USD 26.54 | USD 15.3 bn | 105.71 | Second‑quarter fiscal 2027 results to be released after U.S. market close, 5 Nov 2026. Conference call to be hosted by CEO Aaron Erter and CFO Ryan Lada. |
| APTV | –1.60 % | USD 43.81 | USD 9.2 bn | 20.10 | |
| ICLR | +0.10 % | USD 185.43 | USD 14.3 bn | 205.98 | |
| ALLE | +11.02 % | USD 176.52 | USD 13.5 bn | 20.86 | |
| GL9.IR | +1.28 % | EUR 20.38 | EUR 4.9 bn | 23.76 |
Company Overview
Jazz Pharmaceuticals PLC is a specialty biopharmaceutical company headquartered in Palo Alto, United States. The company focuses on identifying, developing, and commercialising innovative products that address unmet medical needs. Its product portfolio spans narcolepsy, oncology, pain, and psychiatry.
